{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:51:13Z","timestamp":1773694273059,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10096-021-04237-y","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T07:02:31Z","timestamp":1617692551000},"page":"1863-1871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Modifications of CD4 T cells, CD4\/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis"],"prefix":"10.1007","volume":"40","author":[{"given":"Jos\u00e9-Antonio","family":"Gir\u00f3n-Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"M\u00e1rquez-Coello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Guti\u00e9rrez-Saborido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Arizcorreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cuesta-Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-5828","authenticated-orcid":false,"given":"Jos\u00e9-Antonio","family":"Gir\u00f3n-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"4237_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/cid\/cis500","volume":"55","author":"J Berenguer","year":"2012","unstructured":"Berenguer J, Rodr\u00edguez E, Miralles P, Von Wichmann MA, L\u00f3pez-Aldeguer J, Mallolas J et al (2012) GESIDA HIV\/HCV Cohort Study Group. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 55:728\u2013736","journal-title":"Clin Infect Dis"},{"key":"4237_CR2","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/cid\/cit103","volume":"56","author":"JA Mira","year":"2013","unstructured":"Mira JA, Rivero-Ju\u00e1rez A, L\u00f3pez-Cort\u00e9s LF, Gir\u00f3n-Gonz\u00e1lez JA, T\u00e9llez F, de los Santos-Gil I et al (2013) Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus-coinfected patients with compensated cirrhosis. Clin Infect Dis 56:1646\u20131653","journal-title":"Clin Infect Dis"},{"key":"4237_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.29071","volume":"66","author":"J Berenguer","year":"2017","unstructured":"Berenguer J, Rodr\u00edguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ et al (2017) GESIDA HIV\/HCV Cohort Study Group. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus\/hepatitis C virus coinfection. Hepatology 66:344\u2013356","journal-title":"Hepatology"},{"key":"4237_CR4","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/infdis\/jiw372","volume":"214","author":"L Kostadinova","year":"2016","unstructured":"Kostadinova L, Shive CL, Judge C, Zebrowski E, Compan A, Rife K et al (2016) During hepatitis C virus (HCV) infection and HCV-HIV coinfection, an elevated plasma level of autotaxin is associated with lysophosphatidic acid and markers of immune activation that normalize during interferon-free HCV therapy. J Infect Dis 214:1438\u20131448","journal-title":"J Infect Dis"},{"key":"4237_CR5","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.4049\/jimmunol.172.7.4470","volume":"172","author":"S Bas","year":"2004","unstructured":"Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute phase protein. J Immunol 172:4470\u20134479","journal-title":"J Immunol"},{"key":"4237_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","volume":"203","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE et al (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203:780\u2013790","journal-title":"J Infect Dis"},{"key":"4237_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","volume":"210","author":"PW Hunt","year":"2014","unstructured":"Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N et al (2014) Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis 210:1228\u20131238","journal-title":"J Infect Dis"},{"key":"4237_CR8","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL et al (2014) HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8 T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 10:e1004078","journal-title":"PLoS Pathog"},{"key":"4237_CR9","doi-asserted-by":"publisher","first-page":"e85798","DOI":"10.1371\/journal.pone.0085798","volume":"9","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Perez-Elias MJ, Dronda F, Casado JL, Moreno A, Royuela A et al (2014) Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4\/CD8 ratio. PLoS One 9:e85798","journal-title":"PLoS One"},{"key":"4237_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2012.09.013","volume":"66","author":"S Serrano-Villar","year":"2013","unstructured":"Serrano-Villar S, Guti\u00e9rrez C, Vallejo A, Hern\u00e1ndez-Novoa B, D\u00edaz L, Abad Fern\u00e1ndez M et al (2013) The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 66:57\u201366","journal-title":"J Infect"},{"key":"4237_CR11","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","volume":"2","author":"C Mussini","year":"2015","unstructured":"Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E et al (2015) CD4\/CD8 ratio normalization and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV 2:e98\u2013e106","journal-title":"Lancet HIV"},{"key":"4237_CR12","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/QAD.0000000000000650","volume":"29","author":"O Zaegel-Faucher","year":"2015","unstructured":"Zaegel-Faucher O, Bregigeon S, Cano CE, Obry-Roguet V, Nicolino-Brunet C, Tamalet C et al (2015) Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. AIDS 29:1505\u20131510","journal-title":"AIDS"},{"key":"4237_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/QAI.0000000000000928","volume":"72","author":"MH Kuniholm","year":"2016","unstructured":"Kuniholm MH, O\u02bcBrien TR, Prokunina-Olsson L, Augenbraun M, Plankey M, Karim R et al (2016) Association of hepatitis C virus infection with CD4\/CD8 ratio in HIV-positive women. J Acquir Immune Defic Syndr 72:162\u2013170","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4237_CR14","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/QAD.0b013e32833adbb5","volume":"24","author":"M Potter","year":"2010","unstructured":"Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB, Canadian Co-infection Cohort Study Investigators (2010) Impact of hepatitis C viral replication on CD4 T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. AIDS 24:1857\u20131865","journal-title":"AIDS"},{"key":"4237_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/jvh.12101","volume":"20","author":"CG Tsiara","year":"2013","unstructured":"Tsiara CG, Nikolopoulos GK, Dimou NL, Bagos PG, Saroglou G, Velonakis E, Hatzakis A (2013) Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis. J Viral Hepat 20:715\u2013724","journal-title":"J Viral Hepat"},{"key":"4237_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/infdis\/jiy136","volume":"218","author":"LF L\u00f3pez-Cort\u00e9s","year":"2018","unstructured":"L\u00f3pez-Cort\u00e9s LF, Trujillo-Rodr\u00edguez M, B\u00e1ez-Palomo A, Benmarzouk-Hidalgo OJ, Dominguez-Molina B, Milan\u00e9s-Guisado Y et al (2018) Eradication of hepatitis C virus (HCV) reduces immune activation, microbial translocation, and the HIV DNA level in HIV\/HCV-coinfected patients. J Infect Dis 218:624\u2013632","journal-title":"J Infect Dis"},{"key":"4237_CR17","doi-asserted-by":"publisher","first-page":"e0119568","DOI":"10.1371\/journal.pone.0119568","volume":"10","author":"M M\u00e1rquez","year":"2015","unstructured":"M\u00e1rquez M, Romero-Cores P, Montes-Oca M, Mart\u00edn-Aspas A, Soto-C\u00e1rdenas MJ, Guerrero F et al (2015) Immune activation response in chronic HIV-infected patients: influence of hepatitis C virus coinfection. PLoS One 10:e0119568","journal-title":"PLoS One"},{"issue":"RR-03","key":"4237_CR18","first-page":"1","volume":"63","author":"Centers for Disease Control and Prevention (CDC)","year":"2014","unstructured":"Centers for Disease Control and Prevention (CDC) (2014) Revised surveillance case definition for HIV infection--United States, 2014. MMWR Recomm Rep 63(RR-03):1\u201310","journal-title":"MMWR Recomm Rep"},{"key":"4237_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1086\/521857","volume":"45","author":"S Vergara","year":"2007","unstructured":"Vergara S, Mac\u00edas J, Rivero A, Guti\u00e9rrez-Valencia A, Gonz\u00e1lez-Serrano M, Merino D et al (2007) Grupo para el Estudio de las Hepatitis Viricas de la SAEI. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 45:969\u2013974","journal-title":"Clin Infect Dis"},{"key":"4237_CR20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"R Pugh","year":"1973","unstructured":"Pugh R, Murray-lyon I, Dawson J (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646\u2013649","journal-title":"Br J Surg"},{"key":"4237_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(07)60948-9","volume":"370","author":"A Mocroft","year":"2007","unstructured":"Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N et al (2007) Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 370:407\u2013413","journal-title":"Lancet"},{"key":"4237_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/432618","volume":"41","author":"MF Miller","year":"2005","unstructured":"Miller MF, Haley C, Koziel MJ, Rowley CF (2005) Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 41:713\u2013720","journal-title":"Clin Infect Dis"},{"key":"4237_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/169.1.28","volume":"169","author":"MD Hughes","year":"1994","unstructured":"Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA (1994) Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 169:28\u201336","journal-title":"J Infect Dis"},{"key":"4237_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/432955","volume":"192","author":"T Hulgan","year":"2005","unstructured":"Hulgan T, Raffanti S, Kheshti A, Blackwell RB, Rebeiro PF, Barkanic G et al (2005) CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes\/mm3. J Infect Dis 192:950\u2013957","journal-title":"J Infect Dis"},{"key":"4237_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1468-1293.2006.00397.x","volume":"7","author":"DM Moore","year":"2006","unstructured":"Moore DM, Hogg RS, Yip B, Craib K, Wood E, Montaner JS (2006) CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells\/microL. HIV Med 7:383\u2013388","journal-title":"HIV Med"},{"key":"4237_CR26","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/cid\/cis289","volume":"54","author":"MW Hull","year":"2012","unstructured":"Hull MW, Rollet K, Odueyungbo A, Saeed S, Potter M, Cox J et al (2012) Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 54:1798\u20131805","journal-title":"Clin Infect Dis"},{"key":"4237_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1086\/509580","volume":"44","author":"BH McGovern","year":"2007","unstructured":"McGovern BH, Golan Y, Lopez M, Pratt D, Lawton A, Moore G et al (2007) The impact of cirrhosis on CD4 T cell counts in HIV-seronegative patients. Clin Infect Dis 44:431\u2013437","journal-title":"Clin Infect Dis"},{"key":"4237_CR28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/QAD.0b013e3283471d10","volume":"25","author":"G Marchetti","year":"2011","unstructured":"Marchetti G, Cozzi-Lepri A, Merlini E, Bellistr\u00ec GM, Castagna A, Galli M et al (2011) Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4 cell count. AIDS 25:1385\u20131394","journal-title":"AIDS"},{"key":"4237_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/infdis\/jit025","volume":"207","author":"G Mendez-Lagares","year":"2013","unstructured":"Mendez-Lagares G, Romero-Sanchez MC, Ruiz-Mateos E, Genebat M, Ferrando-Mart\u00ednez S, Mu\u00f1oz-Fern\u00e1ndez M\u00c1 et al (2013) Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14. J Infect Dis 207:1221\u20131225","journal-title":"J Infect Dis"},{"key":"4237_CR30","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3748\/wjg.v22.i4.1433","volume":"22","author":"M M\u00e1rquez","year":"2016","unstructured":"M\u00e1rquez M, Fern\u00e1ndez Guti\u00e9rrez del \u00c1lamo C, Gir\u00f3n-Gonz\u00e1lez JA (2016) Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: influence on innate and acquired immunity. World J Gastroenterol 22:1433\u20131448","journal-title":"World J Gastroenterol"},{"key":"4237_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","volume":"153","author":"S Lens","year":"2017","unstructured":"Lens S, Alvarado-Tapias E, Mari\u00f1o Z, Londo\u00f1o MC, LLop E, Martinez J et al (2017) Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis. Gastroenterology 153:1273\u20131283","journal-title":"Gastroenterology"},{"key":"4237_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nm0795-674","volume":"1","author":"JB Margolick","year":"1995","unstructured":"Margolick JB, Mu\u00f1oz A, Donnenberg AD, Park LP, Galai N, Giorgi JV et al (1995) Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med 1:674\u2013680","journal-title":"Nat Med"},{"key":"4237_CR33","doi-asserted-by":"publisher","first-page":"174215","DOI":"10.1155\/2015\/174215","volume":"2015","author":"C Brites-Alves","year":"2015","unstructured":"Brites-Alves C, Netto EM, Brites C (2015) Coinfection by hepatitis C is strongly associated with abnormal CD4\/CD8 ratio in HIV patients under stable ART in Salvador, Brazil. J Immunol Res 2015:174215","journal-title":"J Immunol Res"},{"key":"4237_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcv.2016.05.019","volume":"81","author":"A Saracino","year":"2016","unstructured":"Saracino A, Bruno G, Scudeller L, Ladisa N, de Gennaro N, Allegrini M et al (2016) CD4 and CD4\/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR. J Clin Virol 81:94\u201399","journal-title":"J Clin Virol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04237-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T13:22:29Z","timestamp":1628256149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04237-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4237"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04237-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The ethical research committee of Hospital Puerta del Mar (C\u00e1diz, Spain) approved the project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent to publish"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}